Journal
MEDCOMM
Volume 4, Issue 2, Pages -Publisher
WILEY
DOI: 10.1002/mco2.218
Keywords
cancer metabolism; cancer therapy; glycolysis; metabolic reprogramming
Categories
Ask authors/readers for more resources
Cancer cells require altered metabolic processes to sustain their uncontrolled growth and proliferation. This metabolic reprogramming is mediated by various factors and involves multiple pathways, contributing to the resistance of tumor cells to traditional therapies. Understanding these changes in cancer metabolism can guide the development of new therapeutic approaches. This review provides an overview of the metabolic changes in tumor cells, their regulation, current treatment methods, and potential future treatments.
Cancer cells characterized by uncontrolled growth and proliferation require altered metabolic processes to maintain this characteristic. Metabolic reprogramming is a process mediated by various factors, including oncogenes, tumor suppressor genes, changes in growth factors, and tumor-host cell interactions, which help to meet the needs of cancer cell anabolism and promote tumor development. Metabolic reprogramming in tumor cells is dynamically variable, depending on the tumor type and microenvironment, and reprogramming involves multiple metabolic pathways. These metabolic pathways have complex mechanisms and involve the coordination of various signaling molecules, proteins, and enzymes, which increases the resistance of tumor cells to traditional antitumor therapies. With the development of cancer therapies, metabolic reprogramming has been recognized as a new therapeutic target for metabolic changes in tumor cells. Therefore, understanding how multiple metabolic pathways in cancer cells change can provide a reference for the development of new therapies for tumor treatment. Here, we systemically reviewed the metabolic changes and their alteration factors, together with the current tumor regulation treatments and other possible treatments that are still under investigation. Continuous efforts are needed to further explore the mechanism of cancer metabolism reprogramming and corresponding metabolic treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available